The Europe IVD market is expected to reach over USD 15.5 billion by 2024 according to
a new report by Grand View Research, Inc. This expected increase in the demand
is ascribed to the presence of novel and promising technologies in clinical
laboratories, such as the introduction of Troponin T test by Roche Diagnostics
in May, 2011.
Persistent research and development efforts made to introduce
automation in laboratories that perform analytical testsare projected to propel
the market growth over the forecast period. Clinical laboratory operations
require automated analyzers to cope with the large test volumes,which enhance
the overall operational workflow. It minimizes the need for dedicated operator
training andnegates the risk of human errors. In addition, the rising demand
for portable and handheld IVD devicesis one of the major factors pushing
forward the growth of the market.
The increasing prevalence of chronic diseases, such as diabetes,
cancers, and cardiac dysfunctions and the rising geriatric population coupled
with the rising awareness towards early diagnosis in low-income countries, such
as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe
IVD market.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market
Further key findings from the study suggest:
- In
2015, the reagents segment dominated the Europe IVD market due to its
increasing number of applications in the companion diagnostics area and
the introduction of disease specific kits, such as the XpertTB kit
- The
IVD instruments market is anticipated to show lucrative growth due to the
introduction of portable instruments, such as MinION Analyzer by Oxford
Nanopore, and the availability of various platforms to performtarget
sequence analysis, thereby driving the overall demand
- Germany
is one of the largest segments in 2015 with a share of over 19% owing to
the presence of a larger geriatric population base in this region and the
amendment ofthe German lawfor the prevention of hospital-acquired
infections
- UK is
expected to be the fastest growing regionduring the forecast period.The
rising demand for the point-of-care devices coupled with the government
interventions to incorporate innovative, cost-effective solutions in the
healthcare services are expected to drive the market growth during the
forecast period.
- The
hospital-based IVD testing segment held the largest share of over 45% in
2015. The highprocedure volumes in this segment, is one of the major
reasons resulting inthehigh share and;hence, is anticipated to maintain
its market position over the forecast period.
- The
market players of the Europe IVD market include Alere, Inc., bioMerieux,
Inc., Hologic, Inc. (Gen-Probe), Roche Diagnostics, Qiagen N.V., Bio-Rad
Laboratories, Inc., Quidel Corporation, Abbott Laboratories, Inc., Becton,
Dickinson (BD) and Company, Inc., and Siemens Healthcare GmbH
- The
presence of major IVD market players in Europe accelerates the penetration
of the IVD products throughout the European Union. For instance, in
September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800
systems, which offers IVD-based viral load monitoring withenhanced
flexibility and automation.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment